• 1
    Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford: Clarendon Press, 1999.
  • 2
    Iuchi K, Ichimiya A, Akashi A et al. Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Cancer 1987; 60: 17715.
  • 3
    Gilmour P, Brown D, Beswick P, MacNee W, Rahman I, Donaldson K. Free radical activity of industrial fibers: role of iron in oxidative stress and activation of transcription factors. Environ Health Perspect 1997; 105 (Suppl 5): 131317.
  • 4
    Hodgson J, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 2000; 44: 565601.
  • 5
    Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 7849.
  • 6
    Naito Y, Yoshikawa T. Carcinogenesis and chemoprevention in gastric cancer associated with helicobacter pylori infection: role of oxidants and antioxidants. J Clin Biochem Nutr 2005; 36: 3749.
  • 7
    Collins R, Feldman M, Fordtran J. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med 1987; 316: 16548.
  • 8
    Eaden J, Abrams K, Mayberry J. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 52635.
  • 9
    Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 1996; 20: 55366.
  • 10
    Elmberg M, Hultcrantz R, Ekbom A et al. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology 2003; 125: 173341.
  • 11
    Grodstein F, Speizer F, Hunter D. A prospective study of incident squamous cell carcinoma of the skin in the nurses’ health study. J Natl Cancer Inst 1995; 87: 10616.
  • 12
    Nishigori C, Hattori Y, Toyokuni S. Role of reactive oxygen species in skin carcinogenesis. Antioxid Redox Signal 2004; 6: 56170.
  • 13
    Preston D, Kusumi S, Tomonaga M et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950–87. Radiat Res 1994; 137: S6897.
  • 14
    Li JL, Okada S, Hamazaki S, Ebina Y, Midorikawa O. Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Cancer Res 1987; 47: 18679.
  • 15
    Ebina Y, Okada S, Hamazaki S, Ogino F, Li JL, Midorikawa O. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats. J Natl Cancer Inst 1986; 76: 10713.
  • 16
    Nishiyama Y, Suwa H, Okamoto K, Fukumoto M, Hiai H, Toyokuni S. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate. Jpn J Cancer Res 1995; 86: 11508.
  • 17
    Toyokuni S, Mori T, Dizdaroglu M. DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate. Int J Cancer 1994; 57: 1238.
  • 18
    Toyokuni S, Uchida K, Okamoto K, Hattori-Nakakuki Y, Hiai H, Stadtman ER. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci USA 1994; 91: 261620.
  • 19
    Toyokuni S, Luo XP, Tanaka T, Uchida K, Hiai H, Lehotay DC. Induction of a wide range of C2-12 aldehydes and C7-12 acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radic Biol Med 1997; 22: 101927.
  • 20
    Zhang D, Okada S, Yu Y, Zheng P, Yamaguchi R, Kasai H. Vitamin E inhibits apoptosis, DNA modification, and cancer incidence induced by iron-mediated peroxidation in Wistar rat kidney. Cancer Res 1997; 57: 241014.
  • 21
    Tanaka T, Iwasa Y, Kondo S, Hiai H, Toyokuni S. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats. Oncogene 1999; 18: 37937.
  • 22
    Hiroyasu M, Ozeki M, Kohda H et al. Specific allelic loss of p16INK4A tumor suppressor gene after weeks of iron-mediated oxidative damage during rat renal carcinogenesis. Am J Pathol 2002; 160: 41924.
  • 23
    Tanaka T, Akatsuka S, Ozeki M, Shirase T, Hiai H, Toyokuni S. Redox regulation of annexin 2 and its implications for oxidative stess-induced renal carcinogenesis and metastasis. Oncogene 2004; 23: 39809.
  • 24
    Dutta KKN, Ishinaka Y, Masutani H et al. Thioredoxin-binding protein-2 is a target gene in oxidative stress-induced renal carcinogenesis. Lab Invest 2005; 85: 798807.
  • 25
    Nakatsuka S, Tanaka H, Namba M. Mutagenic effects of ferric nitrilotriacetate (Fe-NTA) on V79 Chinese hamster cells and its inhibitory effects on cell-cell communication. Carcinogenesis 1990; 11: 25760.
  • 26
    Toyokuni S, Sagripanti JL, Hitchins VM. Cytotoxic and mutagenic effects of ferric nitrilotriacetate on L5178Y mouse lymphoma cells. Cancer Lett 1995; 88: 15762.
  • 27
    Gossen J, De Leeuw W, Tan C et al. Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo. Proc Natl Acad Sci USA 1989; 86: 79715.
  • 28
    Kohler S, Provost G, Fieck A et al. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc Natl Acad Sci USA 1991; 88: 795862.
  • 29
    Gondo Y, Shioyama Y, Nakao K, Katsuki M. A novel positive detection system of in vivo mutations in rpsL (strA) transgenic mice. Mutat Res 1996; 360: 114.
  • 30
    Nohmi T, Katoh M, Suzuki H et al. A new transgenic mouse mutagenesis test system using Spi and 6-thioguanine selections. Environ Mol Mutagen 1996; 28: 46570.
  • 31
    Nohmi T, Masumura K. Molecular nature of intrachromosomal deletions and base substitutions induced by environmental mutagens. Environ Mol Mutagen 2005; 45: 15061.
  • 32
    Toyokuni S, Tanaka T, Hattori Y et al. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997; 76: 36574.
  • 33
    Kawai Y, Furuhata A, Toyokuni S, Aratani Y, Uchida K. Formation of acrolein-derived 2′-deoxyadenosine adduct in an iron-induced carcinogenesis model. J Biol Chem 2003; 278: 50 34654.
  • 34
    Toyokuni S, Akatsuka S, Aung TT, Dutta KK. Free radical-induced carcinogenesis: target genes and fragile genome sites. Free Radic Res 2005; 39 (Suppl 1): S30.
  • 35
    Akatsuka S, Aung TT, Dutta KK et al. Contrasting genome-wide distribution of 8-hydroxyguanine and acrolein-modified adenine during oxidative stress-induced renal carcinogenesis. Am J Pathol 2006, in press.
  • 36
    Nakae D, Mizumoto Y, Kobayashi E, Noguchi O, Konishi Y. Improved genomic/nuclear DNA extraction for 8-hydroxydeoxyguanosine analysis of small amounts of rat liver tissue. Cancer Lett 1995; 97: 2339.
  • 37
    Ono T, Miyamura Y, Ikehata H et al. Spontaneous mutant frequency of lacZ gene in spleen of transgenic mouse increases with age. Mutat Res 1995; 338: 1838.
  • 38
    Masumura K, Matsui K, Yamada M et al. Mutagenicity of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in the new gpt delta transgenic mouse. Cancer Lett 1999; 143: 2414.
  • 39
    Masumura K, Matsui M, Katoh M et al. Spectra of gpt mutations in ethylnitrosourea-treated and untreated transgenic mice. Environ Mol Mutagen 1999; 34: 18.
  • 40
    Nohmi T, Suzuki T, Masumura K. Recent advances in the protocols of transgenic mouse mutation assays. Mutat Res 2000; 455: 191215.
  • 41
    Takeiri A, Mishima M, Tanaka K et al. Molecular characterization of mitomycin C-induced large deletions and tandem-base substitutions in the bone marrow of gpt delta transgenic mice. Chem Res Toxicol 2003; 16: 1719.
  • 42
    Cariello N, Piegorsch W, Adams W, Skopek T. Computer program for the analysis of mutational spectra: application to p53 mutations. Carcinogenesis 1994; 15: 22815.
  • 43
    Shibata A, Masutani M, Kamada N et al. Efficient method for mapping and characterizing structures of deletion mutations in gpt delta mice using Southern blot analysis with oligo DNA probes. Environ Mol Mutagen 2004; 43: 2047.
  • 44
    Hamazaki S, Okada S, Ebina Y, Midorikawa O. Acute renal failure and glucosuria induced by ferric nitrilotriacetate in rats. Toxicol Appl Pharmacol 1985; 77: 26774.
  • 45
    Toyokuni S, Akatsuka S. What has been learned from the studies of oxidative stress-induced carcinogenesis: proposal of the concept of oxygenomics. J Clin Biochem Nutr 2006; 39: 310.
  • 46
    Shibutani S, Takeshita M, Grollman AP. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 1991; 349: 4314.
  • 47
    Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997; 387: 14763.
  • 48
    Nakabeppu Y. Regulation of intracellular localization of human MTH1, OGG1, and MYH proteins for repair of oxidative DNA damage. Prog Nucl Acid Res Mol Biol 2001; 68: 7594.
  • 49
    Steenken S. Purine bases, nucleosides, and nucleotides: aqueous solution redox chemistry and transformation reactions of their radical reactions and e and. OH adducts. Chem Rev 1989; 89: 50320.
  • 50
    Dizdaroglu M. Chemical determination of free radical-induced damage to DNA. Free Radic Biol Med 1991; 10: 22542.
  • 51
    Ober M, Muller H, Pieck C, Gierlich J, Carell T. Base pairing and replicative processing of the formamidopyrimidine-dG DNA lesion. J Am Chem Soc 2005; 127: 18 1439.
  • 52
    Hayashi H, Kondo H, Masumura K, Shindo Y, Nohmi T. Novel transgenic rat for in vivo genotoxicity assays using 6-thioguanine and Spi selection. Environ Mol Mutagen 2003; 41: 2539.
  • 53
    Masumura K, Totsuka Y, Wakabayashi K, Nohmi T. Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gpt delta transgenic mouse. Carcinogenesis 2003; 24: 198593.
  • 54
    Masumura K, Kuniya K, Kurobe T, Fukuoka M, Yatagai F, Nohmi T. Heavy-ion-induced mutations in the gpt delta transgenic mouse: comparison of mutation spectra induced by heavy-ion, X-ray, and gamma-ray radiation. Environ Mol Mutagen 2002; 40: 20715.
  • 55
    Horiguchi M, Masumura K, Ikehata H et al. UVB-induced gpt mutations in the skin of gpt delta transgenic mice. Environ Mol Mutagen 1999; 34: 729.
  • 56
    Masumura K, Horiguchi M, Nishikawa A et al. Low dose genotoxicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in gpt delta transgenic mice. Mutat Res 2003; 541: 91102.